文献速递中毒与环境急症消化、代谢与肾脏急症

五个医疗系统中急诊科启动丁丙诺啡治疗的种族和民族差异

Racial and ethnic disparities in emergency department-initiated buprenorphine across five health care systems.
PubMed 文献 · Acad Emerg Med · 2023-02-27
一句话结论在五个医疗系统的21个急诊科中,黑人OUD患者接受丁丙诺啡的几率低于白人(aOR 0.64),西班牙裔患者则更高(aOR 1.41),差异在纳入出院诊断后减弱。

这项二次分析利用EMBED研究(五个医疗系统21个急诊科,评估启动急诊丁丙诺啡的临床决策支持系统)的数据,考察种族和民族在丁丙诺啡获取上的差异。主要结局为接受丁丙诺啡(急诊给药或处方)。黑人患者接受丁丙诺啡的比例为6.4%(51/801),低于白人患者的8.5%(268/3154),OR 0.59(95%CI 0.45-0.78),调整后aOR 0.64(95%CI 0.48-0.84),但纳入出院诊断后aOR 0.75(95%CI 0.56-1.02)。西班牙裔患者接受比例为14.8%(122/822),高于非西班牙裔患者的11.6%(475/4098),调整后aOR 1.41(95%CI 1.08-1.83),纳入出院诊断后aOR 1.32(95%CI 0.99-1.77)。学术与社区急诊科之间按种族(交互作用p=0.97)和民族(交互作用p=0.64)的比值比相似。差异在纳入出院诊断后减弱,因较少的黑人和非西班牙裔患者被诊断为阿片戒断。

要点

  • 黑人OUD患者接受急诊丁丙诺啡的比例为6.4%(51/801),低于白人患者的8.5%(268/3154),OR 0.59(95%CI 0.45-0.78)。
  • 调整年龄、保险、性别、临床医生X-waiver、医院类型和城市化后,黑人患者aOR 0.64(95%CI 0.48-0.84);纳入出院诊断后aOR 0.75(95%CI 0.56-1.02)。
  • 西班牙裔患者接受丁丙诺啡的比例为14.8%(122/822),高于非西班牙裔患者的11.6%(475/4098),调整后aOR 1.41(95%CI 1.08-1.83)。
  • 学术与社区急诊科之间按种族(交互作用p=0.97)和民族(交互作用p=0.64)的比值比相似。
  • 差异在纳入出院诊断后减弱,因较少的黑人和非西班牙裔患者被诊断为阿片戒断。

适用人群与场景

  • 来自五个医疗系统21个急诊科、参与EMBED研究的阿片使用障碍(OUD)患者。

研究设计与关键结果

  • 研究类型为二次分析,数据来自EMBED研究(评估启动急诊丁丙诺啡的临床决策支持系统),覆盖五个医疗系统21个急诊科。
  • 主要结局为接受丁丙诺啡(急诊给药或处方);黑人患者6.4%(51/801) vs 白人患者8.5%(268/3154),OR 0.59(95%CI 0.45-0.78)。
  • 调整年龄、保险、性别、临床医生X-waiver、医院类型和城市化后,aOR 0.64(95%CI 0.48-0.84);纳入出院诊断后aOR 0.75(95%CI 0.56-1.02)。
  • 西班牙裔患者14.8%(122/822) vs 非西班牙裔患者11.6%(475/4098),未调整OR 1.57(95%CI 1.09-1.83),调整后aOR 1.41(95%CI 1.08-1.83),纳入出院诊断后aOR 1.32(95%CI 0.99-1.77)。
  • 学术与社区急诊科之间按种族(交互作用p=0.97)和民族(交互作用p=0.64)的比值比相似。

证据类型、等级与局限

  • 证据类型:二次分析(基于EMBED研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,OUD患者的药物治疗障碍具有异质性;研究必须继续在患者、临床医生和社区层面解决健康不平等的多重驱动因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Opioid overdose deaths have disproportionately impacted Black and Hispanic populations, in part due to disparities in treatment access. Emergency departments (EDs) serve as a resource for patients with opioid use disorder (OUD), many of whom have difficulty accessing outpatient addiction programs. However, inequities in ED treatment for OUD remain poorly understood.

METHODS: This secondary analysis examined racial and ethnic differences in buprenorphine access using data from EMBED, a study of 21 EDs across five health care systems evaluating a clinical decision support system for initiating ED buprenorphine. The primary outcome was receipt of buprenorphine, ED administered or prescribed. Hospital type (academic vs. community) was evaluated as an effect modifier. Hierarchical models with cluster effects for site and clinician were used to assess buprenorphine receipt by race and ethnicity.

RESULTS: Black patients were less likely to receive buprenorphine (6.4% [51/801] vs. White patients 8.5% [268/3154], odds ratio [OR] 0.59, 95% confidence interval [CI] 0.45-0.78). This association persisted after adjusting for age, insurance, gender, clinician X-waiver, hospital type, and urbanicity (adjusted OR [aOR] 0.64, 95% CI 0.48-0.84) but not when discharge diagnosis was included (aOR 0.75, 95% CI 0.56-1.02). Hispanic patients were more likely to receive buprenorphine (14.8% [122/822] vs. non-Hispanic patients, 11.6% [475/4098]) in unadjusted (OR 1.57, 95% CI 1.09-1.83) and adjusted models (aOR 1.41, 95% CI 1.08-1.83) but not including discharge diagnosis (aOR 1.32, 95% CI 0.99-1.77). Odds of buprenorphine were similar in academic and community EDs by race (interaction p = 0.97) and ethnicity (interaction p = 0.64).

CONCLUSIONS: Black patients with OUD were less likely to receive buprenorphine whereas Hispanic patients were more likely to receive buprenorphine in academic and community EDs. Differences were attenuated with discharge diagnosis, as fewer Black and non-Hispanic patients were diagnosed with opioid withdrawal. Barriers to medication treatment are heterogenous among patients with OUD; research must continue to address the multiple drivers of health inequities at the patient, clinician, and community level.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Holland WC, Li F, Nath B, et al. Racial and ethnic disparities in emergency department-initiated buprenorphine across five health care systems. Acad Emerg Med. 2023. PMID: 36660800. doi:10.1111/acem.14668

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。